Socías ME, Cui Z, Le Foll B, Lei J, Stewart S, Anand R, Jutras-Aswad D Sexually transmitted and blood-borne infection risk reduction with methadone and buprenorphine/naloxone among people with prescription-type opioid use disorder: findings from a Canadian pragmatic randomized trial HIV Med PubMed

Bahji A, Bastien G, Bach P, Choi JC, Le Foll B, Lim R, Jutras-Aswad D, Socías ME The association between self-reported anxiety and retention in opioid agonist therapy: findings from a Canadian pragmatic trial Can J Psychiatry PubMed

Lakkadghatwala R, Lane D, Scheuermeyer F, Hilburt J, Buxton J, Johnson C, Nolan S, Sutherland C, Moe J, Daoust R, Dong K, Christenson J, Miles I, Orkin A, Whyte M, Kestler A An emergency-department-initiated outreach program for patients with opioid use disorder is associated with an increase in agonist therapy and engagement in addictions care: a one-year cohort study Subst Abuse Treat Prev Policy PubMed

Bowles J, Mansoor M, Werb D, Kerr T, Bardwell G A qualitative assessment of tablet injectable opioid agonist therapy (TiOAT) in rural and smaller urban British Columbia, Canada: motivations and initial impacts J Subst Use Addict Treat PubMed

Kennedy MC, Tobias S, Dong H, Buxton JA, Lysyshyn M, Tupper KW, Ti L Author reply to letter to the editor in response to "Fentanyl concentration in drug checking samples and risk of overdose death in Vancouver, Canada" Am J Prev Med PubMed

Langlois J, Nolan S, Dickhout P, Cui Z, Paterson J, Fairbairn N, Socías ME The FASTER-BUP study, extended-release injectable buprenorphine for the treatment of opioid use disorder among individuals at high risk of overdose: protocol for an observational prospective study Subst Use Addctn J PubMed

Kennedy MC, Dong H, Tobias S, Buxton J, Lysyshyn M, Tupper K, Ti L Fentanyl concentration in drug checking samples and risk of overdose death in Vancouver, Canada Am J Prev Med PubMed